What are the chances of Enteropathogenic Escherichia coli (EPEC) harboring Shiga toxin (stx) genes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Prevalence of stx Genes in Enteropathogenic Escherichia coli (EPEC)

Enteropathogenic Escherichia coli (EPEC) strains do not typically harbor Shiga toxin (stx) genes, as the presence of stx genes would classify them as Shiga toxin-producing E. coli (STEC) rather than EPEC. This fundamental distinction is critical for proper classification and clinical management.

Classification and Definitions

EPEC and STEC are distinguished primarily by their virulence gene profiles:

  • EPEC: Defined by the presence of the eae gene (encoding intimin) and the ability to form attaching and effacing (A/E) lesions on intestinal cells, but lacking Shiga toxin genes 1
  • STEC: Defined by the presence of Shiga toxin genes (stx1 and/or stx2) 2
  • Atypical EPEC: Possess the eae gene but lack both the bundle-forming pilus (bfpA) gene and stx genes 3

Evolutionary Relationship

The relationship between EPEC and STEC is evolutionarily significant:

  • STEC O26 is believed to have evolved from EPEC O26 strains through the acquisition of stx genes 4
  • Some stx-negative E. coli O157:H7 isolates may represent either:
    • STEC strains that have lost the Stx-encoding bacteriophage during infection or culturing
    • Progenitors of STEC strains that have not yet acquired the Stx phage 5

Prevalence Data

The prevalence of stx genes in strains classified as EPEC is effectively zero by definition, as:

  • The CDC and IDSA guidelines clearly define EPEC as eae-positive but stx-negative 2
  • When an E. coli strain acquires stx genes, it is reclassified as STEC regardless of its other characteristics 1

Diagnostic Implications

This distinction has important diagnostic implications:

  • Simultaneous testing for both O157 STEC and non-O157 STEC is recommended by the CDC 2
  • Laboratory methods should detect both LEE-positive and LEE-negative STEC strains, including culture, EIA, and PCR for detecting stx1 and stx2 genes 1
  • The IDSA recommends that "STEC O157 should be assessed by culture and non-O157 STEC should be detected by Shiga toxin or genomic assays" 2

Clinical Significance

The distinction between EPEC and STEC has significant clinical implications:

  • STEC infections, particularly those with stx2 genes, are associated with increased risk of hemolytic uremic syndrome (HUS) 2, 1
  • Antibiotic therapy in patients with STEC infections might be associated with more severe disease 2
  • Early identification of STEC is crucial for appropriate management, including parenteral volume expansion to reduce renal damage 2

Common Pitfalls in Classification

A key pitfall in clinical practice is the misclassification of EPEC and STEC:

  • Some strains may lose stx genes during culturing or infection, leading to misclassification as EPEC 5
  • Relying solely on stx gene detection without culture confirmation may miss important pathogenic E. coli strains 2
  • Some atypical EPEC strains may represent former STEC that have lost their stx genes 5

In summary, by definition, true EPEC strains do not harbor stx genes. When stx genes are detected, the strain should be classified as STEC, not EPEC, regardless of other virulence factors present.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.